Soliris genopretter derved PNH - patienternes terminale regulering af komplement i blodet og hæmmer den komplementmedierede intravaskulære hæmolyse hos disse patienter.
Soliris therefore restores terminal complement regulation in the blood of PNH patients and inhibits terminal complement mediated intravascular haemolysis in PNH patients.